ARCHIVES

Wistar Investigators Report Oncogene Relation to Burkitt’s

This article is from The Cancer Letter archive.

Vol. 08 No. 46 | November 26, 1982

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

NCI Smoking Nears Goals With “New Generation”

January 9, 1976